NDRG4 is downregulated in glioblastoma and inhibits cell proliferation

OMICS A Journal of Integrative Biology

Volumn 16, Issue 5, 2012, Pages 263-267

  Ding, Wenchao ^a   Zhang, Jing ^a,b   Yoon, Jae Geun ^b   Shi, Dongyan ^c   Foltz, Gregory ^b   Lin, Biaoyang ^a,b,c,d  

^a ZHEJIANG UNIVERSITY   (China)

^b SWEDISH MEDICAL CENTER   (United States)

^c ZHEJIANG UNIVERSITY   (China)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DEVELOPMENT; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; N MYC DOWNREGULATED GENE 4; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; MUSCLE PROTEINS; NERVE TISSUE PROTEINS;

EID: 84860703456     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2011.0146     Document Type: Article

References (19)

1. Deng, Y., Yao, L., Chau, L., Ng, S.S., Peng, Y., Liu, X., et al. (2003). N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 106, 342-347. (Pubitemid 36870394)
2. Gibault, L., Ferreira, C., Perot, G., Audebourg, A., Chibon, F., Bonnin, S., et al. (2011). From PTEN loss of expression to RICTOR role in smooth muscle differentiation: Complex involvement of the mTOR pathway in leiomyosarcomas and pleomorphic sarcomas. Mod Pathol doi:10.1038/modpathol. 2011.163.
3. Hwang, J., Kim, Y., Kang, H.B., Jaroszewski, L., Deacon, A.M., Lee, H., et al. (2011). Crystal structure of the human N-Myc downstream-regulated gene 2 protein provides insight into its role as a tumor suppressor. J Biol Chem 286, 12450-12460.
4. Kehlen, A., Lendeckel, U., Dralle, H., Langner, J., and Hoang-Vu, C. (2003). Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Cancer Res 63, 8500-8506. (Pubitemid 37549507)
5. Kim, Y.J., Yoon, S.Y., Kim, J.T., Song, E.Y., Lee, H.G., Son, H.J., et al. (2009). NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma. Carcinogenesis 30, 598-605.
6. Kovacevic, Z., Fu, D., and Richardson, D.R. (2008). The ironregulated metastasis suppressor, Ndrg-1: Identification of novel molecular targets. Biochim Biophys Acta 1783, 1981-1992.
7. Lin, B., Madan, A., Yoon, J.G., Fang, X., Yan, X., Kim, T.K., et al. (2010). Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma. PLoS One 5, e10210.
8. Liu, Y.L., Bai, W.T., Luo, W., Zhang, D.X., Yan, Y., Xu, Z.K., et al. (2011). Downregulation of NDRG1 promotes invasion of human gastric cancer AGS cells through MMP-2. Tumour Biol 32, 99-105.
9. Ma, J., Jin, H., Wang, H., Yuan, J., Bao, T., Jiang, X., et al. (2008). Expression of NDRG2 in clear cell renal cell carcinoma. Biol Pharm Bull 31, 1316-1320. (Pubitemid 351930639)
10. Malette, B., Cherry, E., Lagace, M., Bernard, M., Gosselin, D., Hugo, P., et al. (2003). Large scale validation of human N-myc downstream-regulated gene (NDRG)-1 expression in endometrium during the menstrual cycle. Mol Hum Reprod 9, 671-679. (Pubitemid 37483955)
11. Melotte, V., Lentjes, M.H., Van den Bosch, S.M., Hellebrekers, D.M., De Hoon, J.P., Wouters, K.A., Daenen, K.L., et al. (2009). N-Myc downstream-regulated gene 4 (NDRG4): A candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 101, 916-927.
12. Mordalska, A., Latek, J., Ferenc, T., Pomorski, L., Galecka, E., Zygmunt, A., et al. (2010). Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes. Thyroid Res 3, 6.
13. Schilling, S.H., Hjelmeland, A.B., Radiloff, D.R., Liu, I.M., Wakeman, T.P., Fielhauer, J.R., et al. (2009). NDRG4 is required for cell cycle progression and survival in glioblastoma cells. J Biol Chem 284, 25160-25169.
14. Shen, L., Zhao, Z.Y., Wang, Y.Z., Ji, S.P., Liu, X.P., Liu, X.W., et al. (2008). Immunohistochemical detection of Ndrg2 in the mouse nervous system. Neuroreport 19, 927-931.
15. Shi, H., Jin, H., Chu, D., Wang, W., Zhang, J., Chen, C., et al. (2009). Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation. Biol Pharm Bull 32, 968-975.
16. Tepel, M., Roerig, P., Wolter, M., Gutmann, D.H., Perry, A., Reifenberger, G., et al. (2008). Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. Int J Cancer 123, 2080-2086.
17. Tschan, M.P., Shan, D., Laedrach, J., Eyholzer, M., Leibundgut, E.O., Baerlocher, G.M., et al. (2010). NDRG1/2 expression is inhibited in primary acute myeloid leukemia. Leuk Res 34, 393-398.
18. Wang, W., Li, Y., Hong, A., Wang, J., Lin, B., and Li, R. (2009). NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth. Int J Cancer 124, 521-530.
19. Zhou, R.H., Kokame, K., Tsukamoto, Y., Yutani, C., Kato, H., and Miyata, T. (2001). Characterization of the human NDRG gene family: A newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73, 86-97. (Pubitemid 32382390)